CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced agreements with leading orthotics and prosthetics practices to bring MyoPro availability to 16 new U.S. locations.
Today’s announcement includes an agreement with Limb Lab, an independently owned and operated boutique prosthetic and orthotic company, to cooperate in two new markets: Jacksonville, Florida, and Scottsdale (Phoenix area), Arizona. Several medical and rehabilitation centers with national acclaim have locations in Jacksonville and Scottsdale. Myomo has recently hired business development managers in both Phoenix and Florida to support expected growth.
Limb Lab’s existing facilities in Rochester and Mankato, Minn., and La Crosse, Wisc., are well-established centers of excellence serving a range of patients, including those suffering from upper limb paralysis as a result of stroke or other neuromuscular disease or injury. Limb Lab frequently fits MyoPro devices for patients who have experienced brachial plexus injuries (BPI) and whose arms are impaired.
Carrie Kaster of Kansas City, Missouri, was fitted with a MyoPro by Limb Lab after a severe motorcycle accident damaged her brachial plexus and after surgery. “My arm was useless, even after surgery,” said Carrie. “I was given the option to amputate. Now, with MyoPro, I can again prepare meals, feed myself and perform many other activities of daily living. It has changed my life.”
Additional new agreements include Reach Orthotics & Prosthetics in Newport News, Chesapeake, Gloucester, and Williamsburg, Virginia; Teter Orthotics & Prosthetics in Traverse City and Grand Rapids, Michigan; and Springer Prosthetics and Orthotics in Lansing and Mount Pleasant, Michigan.
Through other partnerships, MyoPro is also available in Chicago; Indianapolis; Milwaukee; St. Louis and Kansas City, Missouri; and Wichita, Kansas.
Most commercial healthcare plans, multiple Medicaid plans, and many workers’ compensation and Medicare Advantage plans have covered the MyoPro based on medical necessity and the potential to reduce healthcare costs. Eligible veterans may receive a MyoPro through their local VA Medical Center.
About Myomo
Myomo, Inc. is a wearable medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.
